Brief: Newron: Seqirus and Zambon enter into a partnership for parkinson's disease product in Australia and New Zealand
10/01/2017 16:35
Jan 10 (Reuters) - Newron Pharmaceuticals SpA NWRN.S
* Seqirus and Zambon enter into a partnership for
parkinson's disease product in Australia and New Zealand
Source text - http://bit.ly/2i9L8AZ
Further company coverage: NWRN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Newron Pharmaceuticals SpA
See all newsUS FDA flags four deaths in Newron's schizophrenia drug studies (updated)
US FDA cites 4 deaths in Newron's schizophrenia drug trial hold
Brief: Newron Says Topline Data From ENIGMA-TRS 1 Expected In Q1 2027
Brief: Newron Provides Update Following Type A Meeting With The FDA
Brief: Newron Reports Pause Of Enrollment Of New Study Participants In US Centers Of ENIGMA-TRS 2 Study